Blood brothers Labcorp and Quest Diagnostics showed momentum beyond COVID-19 testing and toward areas that grew base business revenue in their third quarter (Q3) 2023 financial reporting. Company leaders called attention to more partnerships and acquisitions of hospital laboratories and outreach lab services. Both companies also launched unique assays—such as blood tests for diagnosis of […]
Q3 2023 Financial Reports Show Growth at Labcorp, Quest
Both firms focused on partnerships and acquisitions, specialty testing, technology, direct-to-consumer tests
- By Robert Michel
- > From the Volume XXX, Number 16 - November 13, 2023 Issue
- Tags: AAV test, AD-Detect, Adam Schechter, Adeno-associated virus, artificial intelligence, ATN profile, automation, Baystate Health, biomarkers, Biopharma, companion diagnostic, COVID-19, direct-to-consumer test, DTC Test, Duchenne muscular dystrophy gene therapy, FDA, Haystack Oncology, in vitro diagnostics, IVD, ivd/lab informatics, Jim Davis, LabCorp, laboratory informatics, Lee Health, Legacy Health, liquid biopsy, Northern Light Health, OnDemand Menopause test, Providence Health and Services, Q3 financial report, Quest Diagnostics, Sarepta Therapeutics, Tower Health, Tufts Medicine, U.S. Food and Drug Administration
